Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Exosomes as regenerative therapeutics for spinal cord injury: mechanisms and clinical prospects

Xiao Y., Cui T., Zhou Y., Su Q., Yi D.

Narrative Review on Spinal Cord Injury, Neuroinflammation, Scar, Chronic Inflammation, published in Front Med (Lausanne) (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Med (Lausanne) (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42089052
PMCID
PMC13135929
DOI
10.3389/fmed.2026.1810270

Abstract (original English)

Exosomes are nanometer-scale extracellular vesicles secreted by cells with a diameter of approximately 30-100 nanometers. Serving as essential messengers for intercellular communication, they play significant roles in both physiological and pathological processes. Their low immunogenicity, excellent tissue penetrability, and high biocompatibility have positioned them as a research focus for disease diagnostic biomarkers and drug delivery vehicles. Spinal cord injury (SCI) is a severe traumatic disorder of the nervous system, often leading to neuronal death, axonal disruption, glial scar formation, and dysregulated inflammatory responses, ultimately resulting in irreversible sensory and motor dysfunction. This review systematically elucidates the pivotal roles of exosomes derived from various cell sources in the repair of SCI. It focuses on how these exosomes target key cellular components including neurons, glial cells, vascular endothelial cells, and immune cells. This interaction modulates core pathological processes such as neuroinflammation, glial scar formation, axonal regeneration, angiogenesis, and apoptosis. By synthesizing current evidence, we aim to unravel the complex regulatory networks mediated by exosomes as intercellular signaling hubs within the SCI microenvironment. Furthermore, this review provides a theoretical foundation for their future development as novel

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research